Drug Designing: Open Access
Open Access

Exposure Adjusted Continuous Reassessment Method (EACRM) - an Adaptive Design Incorporating Time to Toxicity Event for Phase I Dose Finding Studies.

Qi X, Munasinghe W, Hosmane B, Chiu Y and

DOI: 10.4172/2169-0138.1000122

An Insight into Antimicrobial Activity Substituted Benzimidazole Derivatives through QSAR Studies.

Mukesh C Sharma

DOI: 10.4172/2169-0138.1000123